Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Charles River Laboratorie...

    NYSE: CRL · Real-Time Price · USD
    149.58
    -2.31 (-1.52%)
    At close: Jun 13, 2025, 3:59 PM
    149.45
    -0.09%
    After-hours: Jun 13, 2025, 05:29 PM EDT
    -1.52%
    Bid 130
    Market Cap 7.35B
    Revenue (ttm) 4.02B
    Net Income (ttm) -31.56M
    EPS (ttm) -0.6
    PE Ratio (ttm) -249.3
    Forward PE 14.61
    Analyst Hold
    Ask 153
    Volume 484,038
    Avg. Volume (20D) 1,595,152
    Open 150.73
    Previous Close 151.89
    Day's Range 149.26 - 152.63
    52-Week Range 91.86 - 254.15
    Beta 1.48

    About CRL

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol CRL
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for CRL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Why Price Moved

    Why Price Moved is a one-sentence explanation of why a stock is moving higher or down. By removing noise and collecting signals from news, press releases and SEC filings, we can pinpoint the trigger for price movements.
    1 month ago
    +18.68%
    Charles River shares are trading higher after the ... Unlock content with Pro Subscription
    2 months ago
    -28.13%
    Charles River Laboratories shares are trading higher. The stock may be moving up after the FDA stated plans to phase out animal testing requirements for monoclonal antibodies and other drugs.
    news image

    1 week ago · zacks.com

    Why Is Charles River (CRL) Down 0.1% Since Last Earnings Report?

    Charles River (CRL) reported earnings 30 days ago. What's next for the stock?

    news image

    1 week ago · zacks.com

    Charles River Stock May Gain From Extended CHDI Research Deal on HD

    CRL and CHDI Foundation extend their Huntington's disease partnership, boosting integration and global flexibility in drug discovery.

    news image

    1 week ago · businesswire.com

    Charles River Laboratories to Present at William Blair and Jefferies Conferences

    WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories to Present at William Blair and Jefferies Conferences.

    news image

    3 weeks ago · zacks.com

    Should You Continue to Hold Charles River Stock in Your Portfolio?

    CRL stays on investors' radars due to the strength of partnerships and segmental prospects.

    news image

    1 month ago · zacks.com

    Understanding Charles River (CRL) Reliance on International Revenue

    Examine Charles River's (CRL) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.

    news image

    1 month ago · businesswire.com

    Charles River Laboratories to Present at Bank of America Health Care Conference

    WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories to Present at Bank of America Health Care Conference.

    news image

    1 month ago · cnbc.com

    Activist Elliott reaches key agreement with Charles River. Here are three ways to create value

    The firm has three possible paths toward value creation at the drug development company.

    news image

    1 month ago · https://247wallst.com

    Live Nasdaq Composite: Markets Rise on Fed Day Amid Trade Deal Hopes

    Live Updates Live Coverage Has Ended GOOGL Falls 9% 2:51 pm by Gerelyn Terzo Google parent Alphabet (Nasdaq: GOOGL) stock is down a steep 9% to below $150 per share today after an Apple (Nasdaq; AAPL)...

    news image

    1 month ago · https://247wallst.com

    S&P 500 INDEX (SPX) Live: Markets Eye Potential Bullish Trend as Buying Resumes

    Live Updates Live Coverage Has Ended Rates Unchanged, Stagflation Looms 2:20 pm by Gerelyn Terzo The Dow has reversed a deficit, turning a 200-point drop to a 27-point gain after the Federal Reserve k...

    news image

    1 month ago · investopedia.com

    S&P 500 Gains & Losses Today: Stocks Gain in Volatile Session as Markets React to Fed Meeting, Trump Trade Comments

    The S&P 500 broke a two-session losing streak, rising Wednesday as stocks gained ground in volatile trading following the Federal Reserve's decision to keep interest rates unchanged.

    Add to Watchlist